Cationic Peptide and Hyaluronic Acid Composition for Skin Infections
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for microbial skin infections often rely on antibiotics and chemical antiseptics, which can lead to resistant strains and disrupt skin homeostasis, while biofilms formed by pathogens render them resistant to conventional therapies.
Innovation Solution
A topical composition combining a cationic antimicrobial peptide with medium molecular weight hyaluronic acid or its salts, coupled with a lipid, to enhance antimicrobial activity and stimulate natural skin defenses without promoting resistance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics and chemical antiseptics are used to treat microbial skin infections, then antimicrobial effectiveness is improved, but bacterial resistance develops and skin homeostasis is disrupted
Solution Approach 1:
The patent changes the chemical parameters of the antimicrobial agent by using cationic peptides with specific charge densities and molecular weights (1-10 kDa) instead of conventional antibiotics. This parameter change allows the peptide to interact with bacterial membranes through electrostatic bonding while being less prone to inducing resistance, thus maintaining effectiveness without the same harmful side effects
Solution Approach 2:
The patent combines cationic peptides with hyaluronic acid to create a composite formulation. The hyaluronic acid component promotes wound healing and skin homeostasis while the cationic peptide provides antimicrobial activity, achieving both antimicrobial effectiveness and skin protection simultaneously
2Reliability
If cationic antimicrobial peptides are used to fight bacterial infections, then antimicrobial activity is improved, but affinity for bacterial membranes increases which may cause toxicity
Solution Approach 1:
The patent applies local quality by modifying specific regions of the peptide molecule. The cationic peptides are designed with specific charge distributions along their length, allowing them to have high affinity for bacterial membranes (which are negatively charged) while the overall structure and hydrophobicity are controlled to prevent excessive toxicity to host cells
Solution Approach 2:
The patent optimizes physical-chemical parameters of the peptides including molecular weight (1-10 kDa), charge density, and hydrophobicity. These parameter changes allow the peptides to maintain sufficient membrane affinity for effective antimicrobial activity while staying below the threshold for excessive toxicity
3Productivity
If hyaluronic acid of medium molecular weight is used in the composition, then skin penetration and stimulation of natural defenses is improved, but molecular weight must be precisely controlled
Solution Approach 1:
The patent specifies a particular parameter range for hyaluronic acid molecular weight (medium molecular weight, though exact range is not fully specified in the excerpt). This parameter control ensures optimal balance between skin penetration capability and ability to stimulate natural defenses, while providing clear manufacturing specifications
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively treats microbial skin infections by neutralizing microbial endotoxins, mimicking β-defensins to provide rapid anti-infectious effects, modulating inflammation, and promoting tissue repair, with a broad spectrum of activity against Gram-negative and Gram-positive bacteria, viruses, and parasites, while minimizing resistance development.
Implementation Method 1
cationic antimicrobial peptide act on the membrane of bacteria by electrostatic bonding between the cationic peptide and the negatively charged phospholipids found in the external structure of the membrane
Implementation Method 2
After fixation, the peptides modify membrane permeability, forming pores which cause osmolysis and then death of the bacteria
Implementation Method 3
Studies have shown that commensal bacterial flora and pathogenic flora use different beta-defensin induction pathways. Thus, the skin has molecular means to differentiate them and fight against bacteria
Data Source
AI summary
The invention relates to a composition useable in dermatology. The topical antimicrobial dermatological composition for use in human and veterinary medicine comprises in combination at least one cationic antimicrobial peptide and hyaluronic acid of medium molecular weight or a salt thereof. Application to the treatment of cutaneous, integumental or mucous microbial infections.